Phosphoprotein secretome of tumor cells as a source of candidates for breast cancer biomarkers in plasma.
about
A Single Kinase Generates the Majority of the Secreted PhosphoproteomeEvaluating the effects of preanalytical variables on the stability of the human plasma proteomeQuantitative proteomic analysis of histone modificationsVariation and quantification among a target set of phosphopeptides in human plasma by multiple reaction monitoring and SWATH-MS2 data-independent acquisitionIdentifying network biomarkers based on protein-protein interactions and expression data.Targeted phosphoproteomics of insulin signaling using data-independent acquisition mass spectrometry.Multivariate models from RNA-Seq SNVs yield candidate molecular targets for biomarker discovery: SNV-DAMicroRNA-485-5p suppresses cell proliferation and invasion in hepatocellular carcinoma by targeting stanniocalcin 2.Site-specific O-Glycosylation Analysis of Human Blood Plasma ProteinsSystematic network-based discovery of a Fam20C inhibitor (FL-1607) with apoptosis modulation in triple-negative breast cancer.Casein kinases as potential therapeutic targets.Proteomic profiling of the cancer cell secretome: informing clinical research.Crucial considerations for pipelines to validate circulating biomarkers for breast cancer.Extracellular Protein Phosphorylation, the Neglected Side of the Modification.Advances in mass spectrometry-based cancer research and analysis: from cancer proteomics to clinical diagnostics.Immobilized metal affinity chromatography optimized for the analysis of extracellular phosphorylation.Identification of potential tissue-specific cancer biomarkers and development of cancer versus normal genomic classifiers.Gaining insights into cancer biology through exploration of the cancer secretome using proteomic and bioinformatic tools.The crucial role of multiomic approach in cancer research and clinically relevant outcomes.Phosphotyrosine profiling of human cerebrospinal fluid
P2860
Q24338170-CEC7B71E-0F9A-44FC-A29D-910BE5913750Q30372676-4296CFAD-8096-41E4-BF6E-DE9E81DA6F18Q30375585-FFC2A312-2A88-4F9E-B2C7-1263E99DD9CFQ30826158-C450EC61-9FB4-4B71-8BFD-8D33D3EB9CB4Q30965908-7C9E4AFD-23DE-48A7-B068-420987121BB6Q30968898-E8EB5935-FBA1-40BB-970A-031B0956EA68Q35974524-457A2D64-8D25-458A-9FA5-8C9CCF26C22FQ36375091-34684B66-9A6B-4DB5-A9DA-40643C1CE0E4Q36539502-548FE219-0FDE-4DE8-820B-3C1A98BFB66BQ38448169-311A4583-659B-49C3-9C9C-4EB7F125556AQ38632634-18381BB8-5FBB-40C8-B94B-F6564C096060Q38659528-0AEE0A8C-2A8F-4A57-9A07-7BD52FC9F0F2Q38665032-AF41DAA8-E418-4454-A646-B10921B611AEQ38796467-2A4A80DA-1AE3-43DB-9C10-0D1961F9BFACQ38816181-EEF9CC0B-D259-45F0-9B5D-BD3EAA19C8F4Q45267957-C6972F31-043B-4B85-B240-2A11269D5C0FQ45943755-C422C788-21D5-49BD-B159-395205FADBDFQ47716837-FE11CB58-E5F6-4BEB-8521-853E475705ABQ52363678-62A347EC-3D77-4F0A-90E9-3DD259990506Q58747150-9D956C28-2B6F-42E0-8951-84E68FD9B4C6
P2860
Phosphoprotein secretome of tumor cells as a source of candidates for breast cancer biomarkers in plasma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 February 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Phosphoprotein secretome of tu ...... t cancer biomarkers in plasma.
@en
Phosphoprotein secretome of tu ...... t cancer biomarkers in plasma.
@nl
type
label
Phosphoprotein secretome of tu ...... t cancer biomarkers in plasma.
@en
Phosphoprotein secretome of tu ...... t cancer biomarkers in plasma.
@nl
prefLabel
Phosphoprotein secretome of tu ...... t cancer biomarkers in plasma.
@en
Phosphoprotein secretome of tu ...... t cancer biomarkers in plasma.
@nl
P2093
P2860
P356
P1476
Phosphoprotein secretome of tu ...... t cancer biomarkers in plasma.
@en
P2093
Alexandria K Sahu
Anna M Zawadzka
Birgit Schilling
Bradford W Gibson
Christopher C Benz
Michael P Cusack
Penelope Drake
Susan J Fisher
P2860
P304
P356
10.1074/MCP.M113.035485
P577
2014-02-06T00:00:00Z